Sarah D. McDonald and the team developed the guideline with an objective to assess the impact of deferred (delayed) cord clamping (DCC) and umbilical cord milking in singleton and twin gestations on maternal and infant mortality and morbidity. 
For this purpose, the researchers undertook searches of PubMed, Embase, Medline, and Cochrane Library from inception to March 2020 using Medical Subject Heading (MeSH) terms and keywords related to deferred cord clamping and umbilical cord milking. The document was a representation of an abstraction of the evidence rather than a methodological review. 
The authors note, for the ease of implementation, recommendations for preterm versus term infants have been kept distinct. As the preterm period progresses, the risks of prematurity decrease substantially, such that the absolute benefits of deferred (delayed) cord clamping also decrease. 
- In both  preterm (<37 weeks) and extremely preterm (<28 weeks) singletons,  deferred (delayed) cord clamping is recommended for 60 to 120 seconds because  it decreases newborn mortality and morbidity and improves hematological  outcomes after the newborn period. When cord clamping cannot be deferred for a  full 60 to 120 seconds, then deferred (delayed) cord clamping for at least 30  seconds is superior to immediate clamping. Deferred (delayed) cord clamping  should be performed with the infant at or below the level of the introitus or  at the level of the cesarean incision.
- In term  singletons, deferred (delayed) cord clamping is recommended for 60 seconds  because it improves hematological outcomes at birth and past the newborn  period. Deferred (delayed) cord clamping beyond 60 seconds increases the risk  of hyperbilirubinemia requiring phototherapy. Deferred (delayed) cord clamping  can be performed with the infant at or below the level of the introitus, or at the  level of the cesarean incision, or on the mother's abdomen. 
- Stabilization  or resuscitation with an intact cord for longer durations in preterm and term  infants is feasible for centers with appropriate experience and equipment,  although larger trials are needed to understand the benefits and risks.
- for  maintenance of temperature during deferred (delayed) cord clamping:
- preterm  infants should be placed in warm towels, medical-grade plastic bags, or medical-grade plastic wrap to maintain temperature.
- term infants  can be placed in warm towels or on the mother's abdomen.
- In preterm  twins, deferred (delayed) cord clamping is associated with some benefits and  should be considered, except when contraindicated.
- In term  twins, deferred (delayed) cord clamping may be considered based on presumed  extrapolation of benefits in term singletons, except when contraindicated.
- The evidence  regarding the optimal duration of deferred (delayed) cord clamping in twins is  insufficient. Deferred (delayed) cord clamping for 30 to 60 seconds can be  considered.
- When  deferred (delayed) cord clamping is performed, not delaying delivery of the  second twin is recommended.
- Uterotonic  medications increase uterine tone to prevent postpartum hemorrhage:
- In preterm  pregnancies, due to concerns about a potential bolus of blood to preterm  infants, it is recommended that intravenous uterotonic medications be  administered after clamping the cord.
- In term  pregnancies, with lower risk for bolus effects of blood, lower benefits of  deferred cord clamping, and higher risk for maternal postpartum hemorrhage, it  is recommended that intravenous uterotonic medications be administered with the delivery of the anterior shoulder of the final infant. 
- Absolute  contraindications to deferred (delayed) cord clamping are few and include (but  are not limited to) fetal hydrops, the need for immediate resuscitation of  mother or infant (except in centers with appropriate experience and equipment),  disrupted uteroplacental circulation (e.g., bleeding vasa previas), and known  twin-to-twin transfusion syndrome or twin anemia polycythemia sequence.
- Relative  contraindications to deferred (delayed) cord clamping are few but include (in  term infants) risk factors for significant hyperbilirubinemia (e.g.,  significant polycythemia, severe intrauterine growth restriction,  pregestational diabetes), and cases where maternal antibody titers are high or  when the first infant in a pair of monochorionic twins is delivered. In all  these circumstances, immediate cord clamping should be considered.
- Cautions  regarding deferred (delayed) cord clamping are few but include (in preterm  infants) risk factors for significant hyperbilirubinemia (e.g., significant  polycythemia, severe intrauterine growth restriction, and cases where maternal  antibody titers are high or when the first infant in a pair of monochorionic  twins is delivered. In all these circumstances, discussion with the newborn's  care providers regarding benefits and risks and the duration of deferred  (delayed) cord clamping is encouraged. The infant's gestational age should be  taken into account, with consideration of deferral for 30 seconds.
- Umbilical  cord milking is not recommended in very preterm infants <32 weeks, due to the increased risk for severe intraventricular hemorrhage.
- In preterm  and term infants, deferred (delayed) cord clamping should be performed instead  of umbilical cord milking.
                    KEYWORDS: umbilical cord, umbilical cord blood, ligation, parturition, time factors, term birth, infant, premature, jaundice, neonatal, preterm, cord clamping, milking, infant mortality, infant morbidity, Sarah D. McDonald, Society of Obstetricians and Gynaecologists of Canada, Canadian Paediatric Society 
 
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.